Isolated adrenal cells: Log dose response curves for steroidogenesis induced by ACTH1–24, ACTH1–10, ACTH4–10 and ACTH5–10  by Schwyzer, Robert et al.
Volume 19, number 3 FEBS LETTERS IDecember 197 1 
ISOLATED ADRENAL CELLS: LOG DOSE RESPONSE CURVES 
FOR STEROIDOGENESIS INDUCED BY ACTH,_,, , 
ACT&, , ACTI-&, AND ACTH,_,, 
Robert SCHWYZER, Peter SCHILLER, Steven SEELIG and George SAYERS 
Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, 
8049 Ziirich, Switzerland 
and 
Department of Physiology, Case Western Reserve UniversiTy, School of Medicine, 
Cleveland, Ohio, USA 
Received 7 October 1971 
I. Introduction 
ACTHr-39 * increases the production of cortico- 
sterone when added to suspensions of isolated rat 
adrenal cells [ 1 ] . Response and dose are related by 
the expression BIB,, = A/(A +AsO) where B is the 
rate of corticosterone production, B,,, is the maxi- 
mum rate of corticosterone production, A is the dose 
of ACTH and A,, is the dose required to induce i 
B max [2] _ According to the model proposed by Ariens 
[3l,A,,, an apparent dissociation constant, is the 
reciprocal of the affinity of the hormone for its 
receptor, and B,,, is a measure of the effectiveness 
with which the hormone interacts with its receptor 
(“intrinsic activity”). In contrast to conventional 
methods of assay [4-61 , the isolated adrenal cell 
technique provides measures of both affinity and 
“intrinsic activity”, information of some importance 
to the understanding of the relation of structure to 
biological action among members of a series of poly- 
peptides related to ACTH. 
* The following abbreviations of amino acids and peptides are 
used @UPAC-IUB Commission on Biochemical Nomencla- 
ture, Etzropean J. Biochem. 1 (1967) 375): ACTH = 
ACTH,_sa = porcine adrenocorticotrophic hormone; 
ACTH r _24 = corticotrophin-( 1- 24)-tetracosipeptide; 
ACTHt-,,, = corticotrophin-(1-10)dekapeptide; 
ACTH,_,, = corticotrophin-(4-10)heptapeptide; 
ACTI&ie = corticotrophir-(S-lO)-hexapeptide; 
ACTH 1r-a~ = corticotrophin-(I l-24)-tetradecapeptide. 
North-Holland Pu blishing Company - Amsterdam 
An analysis of log dose response (LDR) curves 
constructed on the basis of the increased production 
of corticosterone which follows addition of ACTHr _24, 
ACTHr _re and ACTH4 _re to suspensions of isolated 
adrenal cells indicates that these polypeptides vary 
widely in potency (variations in A, ,, ‘s) but exhibit 
the same maximum biological response (Bmax) as the 
natural agonist, ACTHr -a9. It appears that the full 
complement of amino acids (“active center”) involved 
in activation of receptor resides in the region 4- 10 of 
the ACTH molecule. 
At the highest dose tested, ACTH, _re significantly 
increased corticosterone production. 
2. Materials and methods 
ACTH, _24 was synthesized according to Schwyzer 
and Kappeler [ 71 and generously provided as 
Synacthen by Dr. Rittel, CIBA-Geigy AG, Basel, 
Switzerland, and as Cortrosyn by Dr. H. Strade, 
Organon Ltd., West Orange, New Jersey. ACTHi_!e, 
ACTH+_ r0 and ACTHs _ I o were synthesized according 
to Schwyzer and Kappeler [8] , Kappeler and 
Schwyzer [9] and Kappeler ] IO] and were generously 
provided by Dr. W. Rittel. The protective groups were 
cleaved with trifluoroacetic acid, and the peptides 
isolated as pure acetates after ion-exchange chromato- 
graphy and gel filtration. Insulin and glucagon were 
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gifts of Dr. 0. Behrens, Eli Lilly Co., Indianapolis, 
Indiana. 
Suspensions of cells of the rat adrenal cortex were 
prepared by the trypsin method of Sayers et al. [l] . 
The pellet of harvested cells was washed twice with 
Krebs-Ringer bicarbonate buffer (KRB) containing 
glucose, 2%, lima bean trypsin inhibitor, O.l%, and 
bovine serum albumin (BSA), 0.5% to remove trypsin. 
The washed pellet was resuspended in 60 ml KRB 
containing calcium, 7.65 mM, glucose, 0.2%, and BSA, 
0.5%. Aliquots of the suspension, 0.9 ml in volume, 
together with 0.1 ml of vehicle or with 0.1 ml of 
Trehicle to which had been added ACTH, were incub- 
ated in an atmosphere of 95% O,-5% CO, at 37”. At 
the end of incubation, methylene chloride was added 
and an aliquot of the methylene chloride phase analyzed 
for corticosterone [ 1 l] . 
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Fig. 1. B production by aliquots of a suspension of isolated 
adrenal cells in response to ACTH,,,, o; ACTHI_,,, o; 
ACTH4 -to, q and ACTH, _ro, 0. The points are averages of 
B analyses on duplicate incubates of cell suspension. The 
values are net, B in aliquots to which ACTH was added minus 
B in aliquots to which vehicle only was added. Aliquots in- 
cubated 60 min at 37” in 95% 02-S% CO2. B in blanks in- 
cubated 60 min equaled 0.05 and 0.05 ng. 
Table 1 
Molar potencies of ACI’H polypeptides assayed by steroido- 
genesis. 
-- 
Polypeptide Potency* 
ACTH , _sa 100 
ACTH r -24 140+ 
ACTH, -ro .37x 10-4 
ACTH,_,, .75 x 10-4 
ACTH, -to .22 x 10-s** 
Molar potencies of synthetic polypeptides expressed as reci- 
procals of their Aso’s relative to ACTH, _ss, which is assigned 
a value of 100. 
1 
* Potency = x 100 
Aso in moles 
+ Responses to various doses of ACTHt_aa and of ACTHr44 
added to aliquots of a single suspension of isolated adrenal 
cells, have been determined and complete LDR curves con- 
structed and analyzed. The two polypeptides have the 
same Emax; ACTH, -24 is estimated to be 40% more 
active than ACTHt -se on a molar basis. 
** Based on response at highest dose tested (1 mg) and on 
the assumption that Bmax equals that of ACTH. 
3. Results and discussion 
ACTHI_ and ACTHI _24 have about the same 
potency and exhibit the same I?,, when added to 
suspensions of isolated adrenal cells (see table 1). LDR 
curves for ACTHr -24, ACTHr _ra and ACTH4-r. are 
displayed in fig. 1. These compounds varied widely 
in potency but exhibited the same B,,, estimated 
by computer to be 1 .l yg B/60 min. At the highest 
dose tested (1 mg), ACTH, ._re induced a response 
approximately one-third the B,, of ACTH, -24. 
Relative molar potencies are presented in table 1. The 
fact that ACTH4_,, appears to be about twice as 
active as ACTHr-,e on a molar basis is interesting 
and we offer no explanation at this time. 
To date, ACTH,_rc is the smallest fragment of the 
ACTH molecule demonstrated to exhibit biological 
activity [ 121. The isolated adrenal cell technique 
reveals that ACTHr_ro and in addition, ACTH4_r0 
and ACTHs _re possess teroidogenic activity. That 
the responses are non-specific is hardly likely since 1 
mg of insulin, 1 mg of glucagon or 1 mg of a mixture 
of amino acids 1-13 of the N-terminal of ACTH (in 
the molar ratios characteristic of the hormone) fail to 
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stimulate B production when added to suspensions of 
isolated adrenal cells. 
Biological activity is determined by both the 
affinity of the hormone for the receptor, as reflected 
in displacement of the LDR curves along the abscissa, 
and the capacity of the hormone to activate the 
receptor (“efficacy” [ 131 , “intrinsic activity” [3] ), 
as reflected in the value of B,, (for discussion of 
these concepts as applied to oxytocin and analogues, 
see [ 141). In this connection [Trp (N~s)~ ] ACTH, _sg , 
an o-nitrophenyl sulfenyl derivative of ACTH, exhibits 
aBmax approx. 0.6 that of ACTHi-sg (Seelig, Kumar 
and Sayers, unpublished observation) and is classified 
as a partial agonist. Furthermore, since ACTH, _ re is 
an agonist (same B,, as ACTH, -sg), we suggest hat 
the “active center” of the ACTH molecule resides in 
the region 4-10. Fujino et al. [15] report that 
ACTHs_23 amide exhibits weak steroidogenic activity 
when tested in viva This information, together with 
the data presented in this report, indicates that the 
amino acids in the region 5-10 are capable of at least 
partial activation of the receptor. 
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